Clinical Trial Update: Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy of co-administering bilastine and montelukast in patients with seasonal allergic rhinoconjunctivitis and asthma; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Seasonal Allergic Rhinoconjunctivitis

Drugs mentioned

• Bilastine (bilastine)
• Montelukast (Montelukast)

Snippet

Sponsor: Menarini International Operations Luxembourg SA | Conditions: Seasonal Allergic Rhinoconjunctivitis, Asthma | Phase 4 | Status: COMPLETED | Results posted: 2019-07-12